Ubs Group Ag Procaps Group, S.A. Transaction History

Ubs Group Ag

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$2.78 - $4.7 $86,141 - $145,634	-30,986 Reduced 99.86%	42 $0
Q4 2023 Feb 09, 2024	BUY	$2.18 - $4.14 $67,641 - $128,455	31,028 New	31,028 $126,000
Q2 2023 Aug 11, 2023	BUY	$3.84 - $5.04 $3 - $5	1 New	1 $0
Q4 2022 Feb 08, 2023	BUY	$4.89 - $7.37 $4,166 - $6,279	852 New	852 $4,000
Q2 2022 Aug 10, 2022	SELL	$7.33 - $9.4 $7,586 - $9,729	-1,035 Reduced 95.39%	50 $0
Q1 2022 May 16, 2022	BUY	$7.97 - $9.85 $581 - $719	73 Added 7.21%	1,085 $9,000
Q4 2021 Feb 14, 2022	BUY	$8.85 - $10.42 $8,584 - $10,107	970 Added 2309.52%	1,012 $10,000
Q3 2021 Nov 15, 2021	BUY	$9.25 - $10.76 $388 - $451	42 New	42 $0

195K

Ticker PROC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 112,824,000
Market Cap $201M
Description
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.